Gene: MLXIPL

51085
CHREBP|MIO|MLX|MONDOB|WBSCR14|WS-bHLH|bHLHd14
MLX interacting protein like
protein-coding
7q11.23
Ensembl:ENSG00000009950 MIM:605678 Vega:OTTHUMG00000129995 UniprotKB:Q9NP71
NG_009307.1
PubMed
0   ANCO-SNPs
ND
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
7.843e-1 (AD)  1.592e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MICAL10.905
CENPT0.899
NEIL10.887
TMEM1450.884
IFFO10.873
AP1G20.873
SRRM30.871
RTEL10.87
ATP13A10.867
CACNA1A0.864

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.508
OR4F29-0.478
ANXA13-0.392
LRAT-0.385
DNAI2-0.364
PDE11A-0.352
SETD9-0.341
CRYBG3-0.34
SGMS2-0.339
CTNNA3-0.334

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the localization of MLXIPL protein"27180240
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of MLXIPL mRNA"27180240
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"NR1I3 protein affects the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the localization of MLXIPL protein]"27180240
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"NR1I3 protein affects the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of MLXIPL mRNA]"27180240
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of MLXIPL mRNA"18648102
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLXIPL mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLXIPL mRNA"27188386
C4750936-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime"6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of MLXIPL mRNA"27180240
D000082AcetaminophenAcetaminophen results in decreased expression of MLXIPL mRNA26690555
D000082AcetaminophenAcetaminophen affects the expression of MLXIPL mRNA17562736
D000082AcetaminophenAcetaminophen results in decreased expression of MLXIPL mRNA19420014
C560978aegeline[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA28843594
D016604Aflatoxin B1Aflatoxin B1 affects the expression of MLXIPL protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of MLXIPL mRNA22100608|2715375
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of MLXIPL mRNA19770486
D000638AmiodaroneAmiodarone results in decreased expression of MLXIPL mRNA28962527
D000069059Atorvastatin CalciumAtorvastatin Calcium inhibits the reaction [Fructose affects the localization of and results in increased activity of MLXIPL protein]19053045
D000069059Atorvastatin CalciumAtorvastatin Calcium inhibits the reaction [Fructose results in increased expression of MLXIPL protein]21122807
D000069059Atorvastatin CalciumN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin Calcium inhibits the reaction [Fructose results in increased activity of MLXIPL protein]]19053045
D001280AtrazineAtrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA]24440342
C547126AZM551248AZM551248 results in decreased expression of MLXIPL mRNA22323515
D001564Benzo(a)pyreneBenzo(a)pyrene affects the expression of MLXIPL mRNA22342234
D001564Benzo(a)pyreneBenzo(a)pyrene promotes the reaction [AHR protein binds to MLXIPL promoter]19654925
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of MLXIPL mRNA19770486
C543008bis(4-hydroxyphenyl)sulfonebis(4-hydroxyphenyl)sulfone results in increased expression of MLXIPL mRNA27685785
C006780bisphenol Abisphenol A results in increased expression of MLXIPL mRNA25619500
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA28628672
C006780bisphenol Abisphenol A affects the expression of MLXIPL mRNA21932408
C006780bisphenol Abisphenol A affects the expression of MLXIPL protein21932408
C006780bisphenol Abisphenol A affects the methylation of MLXIPL promoter27334623
C006780bisphenol Abisphenol A results in decreased expression of MLXIPL mRNA25181051
D019256Cadmium ChlorideCadmium Chloride results in increased expression of MLXIPL mRNA26352046
D002110Caffeine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA28843594
D002251Carbon TetrachlorideCarbon Tetrachloride results in decreased expression of MLXIPL mRNA27339419
D017332CetirizineAPOE gene mutant form inhibits the reaction [Cetirizine results in decreased expression of MLXIPL mRNA]24852568
D017332CetirizineCetirizine results in decreased expression of MLXIPL mRNA24852568
D002784CholesterolAtrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA]24440342
D002784Cholesterol[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA24440342
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MLXIPL mRNA22872676
D002922CiguatoxinsCiguatoxins affects the expression of MLXIPL mRNA18353800
C004690coclaurine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA28843594
D019327Copper SulfateCopper Sulfate results in decreased expression of MLXIPL mRNA19549813
C030973cupric oxidecupric oxide results in increased expression of MLXIPL mRNA22077320
D003471CuprizoneCuprizone results in increased expression of MLXIPL mRNA27523638
D016572CyclosporineCyclosporine results in decreased expression of MLXIPL mRNA20106945|2556210
D016572CyclosporineCyclosporine results in decreased methylation of MLXIPL promoter27989131
C014347decitabinedecitabine affects the expression of MLXIPL mRNA23300844
D003907DexamethasoneDexamethasone results in increased expression of MLXIPL mRNA25047013
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of MLXIPL mRNA28628672
D002945CisplatinCisplatin affects the expression of MLXIPL mRNA23300844
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in increased expression of MLXIPL mRNA27392435
D002945CisplatinCisplatin results in increased expression of MLXIPL mRNA27392435|2759478
C000944dicrotophosdicrotophos results in increased expression of MLXIPL mRNA28302478
D004041Dietary FatsDietary Fats results in increased expression of MLXIPL mRNA22658938
D004041Dietary Fats[Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of MLXIPL mRNA19509184
D004041Dietary FatsANGPTL4 protein modified form affects the reaction [Dietary Fats affects the expression of MLXIPL mRNA]28842503
D004041Dietary FatsDietary Fats affects the expression of MLXIPL mRNA28842503
D004041Dietary FatsDietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of MLXIPL mRNA]27713108
D004041Dietary FatsDietary Fats results in increased expression of MLXIPL mRNA27713108
D004041Dietary FatsTetrachlorodibenzodioxin inhibits the reaction [Dietary Fats results in increased expression of MLXIPL mRNA]27713108
C118739entinostatentinostat results in increased expression of MLXIPL mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLXIPL mRNA"27188386
D000431EthanolEthanol results in increased activity of MLXIPL protein18620774
D000431EthanolEthanol results in increased expression of MLXIPL mRNA18620774
D000431Ethanolpirinixic acid inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA]18620774
D000431EthanolEthanol results in increased expression of MLXIPL mRNA27989594
D000431EthanolEthanol results in increased expression of MLXIPL protein27989594
D000431Ethanolsalvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA]27989594
D000431Ethanolsalvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL protein]27989594
D000431EthanolSIRT1 protein affects the reaction [Ethanol results in increased expression of MLXIPL protein]27989594
D000431EthanolSIRT1 protein affects the reaction [salvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL protein]]27989594
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of MLXIPL mRNA17555576
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of MLXIPL mRNA17942748
D005227Fatty AcidsFatty Acids results in increased expression of MLXIPL mRNA22658938
D005231Fatty Acids, Unsaturated"Fatty Acids, Unsaturated affects the localization of MLXIPL protein"16644726
C093230fexofenadineAPOE gene mutant form inhibits the reaction [fexofenadine results in decreased expression of MLXIPL mRNA]24852568
C093230fexofenadinefexofenadine results in decreased expression of MLXIPL mRNA24852568
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MLXIPL mRNA22872676
D005632Fructose[Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of MLXIPL mRNA19509184
D005632FructoseFGF21 gene mutant form inhibits the reaction [Fructose results in increased expression of MLXIPL mRNA alternative form]28123933
D005632FructoseFructose results in decreased expression of MLXIPL mRNA28123933
D005632FructoseFructose results in increased expression of MLXIPL mRNA alternative form28123933
D005632FructoseMLXIPL gene mutant form inhibits the reaction [Fructose results in increased expression of FGF21 mRNA]28123933
D005632FructoseMLXIPL gene mutant form inhibits the reaction [Fructose results in increased secretion of FGF21 protein]28123933
D005632FructoseAtorvastatin Calcium inhibits the reaction [Fructose affects the localization of and results in increased activity of MLXIPL protein]19053045
D005632FructoseAtorvastatin Calcium inhibits the reaction [Fructose results in increased expression of MLXIPL protein]21122807
D005632FructoseFructose affects the localization of and results in increased activity of MLXIPL protein19053045
D005632FructoseFructose results in increased activity of MLXIPL protein19799862
D005632FructoseFructose results in increased expression of MLXIPL mRNA18346472
D005632FructoseFructose results in increased expression of MLXIPL protein21122807
D005632FructoseN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin Calcium inhibits the reaction [Fructose results in increased activity of MLXIPL protein]]19053045
C039281furanfuran results in decreased expression of MLXIPL mRNA26194646
D005947GlucoseGlucose results in increased expression of MLXIPL protein16644726|1679084
C010176halofuginonehalofuginone results in decreased expression of MLXIPL mRNA17180598
C012348higenamine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA28843594
D017313FenretinideFenretinide results in increased expression of MLXIPL mRNA28973697
D047348Hydrolyzable Tannins[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA28843594
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of MLXIPL mRNA28628672
C051890irinotecanirinotecan affects the expression of MLXIPL mRNA20097248
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of MLXIPL mRNA28628672
C544151jinfukang[Cisplatin co-treated with jinfukang] results in increased expression of MLXIPL mRNA27392435
C029310lardAtrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA]24440342
C029310lard[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA24440342
C482199lipopolysaccharide, E coli O55-B5"[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MLXIPL mRNA"18930950
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MLXIPL mRNA22872676
C063509N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin Calcium inhibits the reaction [Fructose results in increased activity of MLXIPL protein]]19053045
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of MLXIPL mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of MLXIPL mRNA"25554681|2562005
C051752nefazodonenefazodone results in decreased expression of MLXIPL mRNA24136188
D009525NiacinNiacin results in decreased expression of MLXIPL protein19878707
D015525Fatty Acids, Omega-3"Fatty Acids, Omega-3 results in decreased expression of MLXIPL mRNA"23333450
D015525Fatty Acids, Omega-3"NR1H2 gene mutant form promotes the reaction [Fatty Acids, Omega-3 results in decreased expression of MLXIPL mRNA]"23333450
D015525Fatty Acids, Omega-3"NR1H3 gene mutant form promotes the reaction [Fatty Acids, Omega-3 results in decreased expression of MLXIPL mRNA]"23333450
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in increased expression of MLXIPL mRNA23948077
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of MLXIPL mRNA27153767
C027579periodate-oxidized adenosineperiodate-oxidized adenosine affects the expression of MLXIPL mRNA17097637
D010795Phthalic AcidsPhthalic Acids results in decreased expression of MLXIPL mRNA15728792
C006253pirinixic acidpirinixic acid inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA]18620774
C006253pirinixic acidpirinixic acid results in decreased expression of MLXIPL mRNA18445702
C006253pirinixic acidMLXIPL protein inhibits the reaction [pirinixic acid results in decreased expression of PKLR mRNA]16644726
C076944salvianolic acid Bsalvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA]27989594
C076944salvianolic acid Bsalvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL protein]27989594
C076944salvianolic acid BSIRT1 protein affects the reaction [salvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL protein]]27989594
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of MLXIPL mRNA25895662
D018038Sodium SeleniteSodium Selenite results in decreased expression of MLXIPL mRNA23274088
D013395SucroseAtrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA]24440342
D013395Sucrose[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA24440342
D013629TamoxifenTamoxifen affects the expression of MLXIPL mRNA17555576
D013749TetrachlorodibenzodioxinDietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of MLXIPL mRNA]27713108
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of MLXIPL mRNA26377647
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin inhibits the reaction [Dietary Fats results in increased expression of MLXIPL mRNA]27713108
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of MLXIPL mRNA26290441|2771310
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of MLXIPL mRNA17942748
D013853ThioacetamideThioacetamide results in decreased expression of MLXIPL mRNA23411599
C423915TO-901317[Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of MLXIPL mRNA19509184
C423915TO-901317TO-901317 results in increased expression of MLXIPL mRNA23333450|2359174
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of MLXIPL mRNA28065790
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of MLXIPL mRNA"26179874
C013320tris(2-butoxyethyl) phosphatetris(2-butoxyethyl) phosphate affects the expression of MLXIPL mRNA29024780
C080163trovafloxacin"[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MLXIPL mRNA"18930950
D014520UrethaneUrethane results in decreased expression of MLXIPL mRNA28818685
D014635Valproic AcidValproic Acid results in decreased expression of MLXIPL mRNA29154799
D015016Yohimbine[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA28843594

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISA-  
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISM19274049  
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-NAS19274049  
GO:0001078transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding-IEA-  
GO:0003677DNA bindingcontributes_toISS11230181  
GO:0003677DNA binding-NAS10780788  
GO:0003700DNA-binding transcription factor activity-IBA21873635  
GO:0003700DNA-binding transcription factor activity-NAS10780788  
GO:0008134transcription factor binding-IPI11230181  
GO:0035538carbohydrate response element binding-TAS18591247  
GO:0042803protein homodimerization activityNOTIDA11230181  
GO:0046982protein heterodimerization activity-IPI11230181  
GO ID GO Term Qualifier Evidence PubMed
GO:0000122negative regulation of transcription by RNA polymerase II-IEA-  
GO:0006351transcription, DNA-templated-IEA-  
GO:0006355regulation of transcription, DNA-templated-NAS10780788  
GO:0006357regulation of transcription by RNA polymerase II-IBA21873635  
GO:0008284positive regulation of cell proliferation-IMP19995986  
GO:0009653anatomical structure morphogenesis-TAS9860302  
GO:0010255glucose mediated signaling pathway-ISS-  
GO:0033137negative regulation of peptidyl-serine phosphorylation-IMP19995986  
GO:0035556intracellular signal transduction-TAS-  
GO:0042593glucose homeostasis-ISS11230181  
GO:0045723positive regulation of fatty acid biosynthetic process-ISS11230181  
GO:0045821positive regulation of glycolytic process-IMP19995986  
GO:0045892negative regulation of transcription, DNA-templated-ISS11230181  
GO:0045893positive regulation of transcription, DNA-templated-ISS11230181  
GO:0045944positive regulation of transcription by RNA polymerase II-ISS11230181  
GO:0046889positive regulation of lipid biosynthetic process-IMP19995986  
GO:0055089fatty acid homeostasis-ISS-  
GO:0070328triglyceride homeostasis-NAS19571538  
GO:0071157negative regulation of cell cycle arrest-IMP19995986  
GO:0090324negative regulation of oxidative phosphorylation-IMP19995986  
GO:0097009energy homeostasis-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IBA21873635  
GO:0005634nucleus-IDA-  
GO:0005634nucleus-ISS11230181  
GO:0005634nucleus-NAS10780788  
GO:0005654nucleoplasm-TAS-  
GO:0005667transcription factor complex-NAS11230181  
GO:0005737cytoplasm-ISS11230181  
GO:0005829cytosol-IDA-  
GO:0005829cytosol-TAS-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1430728MetabolismTAS
R-HSA-1430728MetabolismIEA
R-HSA-163358PKA-mediated phosphorylation of key metabolic factorsIEA
R-HSA-163358PKA-mediated phosphorylation of key metabolic factorsTAS
R-HSA-163680AMPK inhibits chREBP transcriptional activation activityIEA
R-HSA-163685Integration of energy metabolismTAS
R-HSA-163685Integration of energy metabolismIEA
R-HSA-163765ChREBP activates metabolic gene expressionTAS
R-HSA-163765ChREBP activates metabolic gene expressionIEA
R-HSA-163767PP2A-mediated dephosphorylation of key metabolic factorsIEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
27854512Genetic and Environmental Biomarkers Associated with Triglyceride Levels in Two Groups of Slovak Women. (2017 Jan)Dankova ZGenet Test Mol Biomarkers
25288136Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. (2015 May)Cornelis MCMol Psychiatry